To determine antimicrobial drug resistance mechanisms of Shigella spp., we analyzed 344 isolates collected in Switzerland during 2004–2014. Overall, 78.5% of isolates were multidrug resistant; 10.5% were ciprofloxacin resistant; and 2% harbored mph(A), a plasmid-mediated gene that confers reduced susceptibility to azithromycin, a last-resort antimicrobial agent for shigellosis.
Ahead of Print -Shigella Antimicrobial Drug Resistance Mechanisms, 2004–2014 - Volume 22, Number 6—June 2016 - Emerging Infectious Disease journal - CDC
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.